fmb-2022-0014_Suppl1.docx (299.45 kB)
Download file

fmb-2022-0014 Supplementary Figure 1.

Download (299.45 kB)
figure
posted on 09.02.2022, 08:45 by Sabine Hazan, Sonya Dave, Anoja W. Gunaratne, Sibasish Dolai, Robert L Clancy, Peter A. McCullough, Thomas J. Borody
Example of symptom log sheet used by subjects.

Funding

Funding This study was funded by ProgenaBiome, LLC. SH declares that she has pecuniary interest in Topelia Pty Ltd in Australia, and Topelia Pty Ltd in USA where development of COVID-19 preventative/treatment options are being pursued. She has also filed patents relevant to Coronavirus treatments. She is the founder and owner of Microbiome Research Foundation, Progenabiome and Ventura Clinical Trials. TJB declares that he has pecuniary interest in Topelia Pty Ltd in Australia, and Topelia Therapeutics Inc. in USA developing COVID-19 preventative/treatment medications. He has also filed patents relevant to COVID-19 treatments. S. Dave declares she has corporate affiliation to McKesson Specialty Health / Ontada and North End Advisory, LLC, and affiliation to Microbiome Research Foundation (a non-profit). S. Dave is unaware of and not directly involved in COVID-19 treatment relevant projects at McKesson, but they may exist.

History